Breaking the Cognition Barrier: my interview with LabGenius Therapeutics VP of Computational Science, Dr Winston Haynes is now live at Technology Networks.
https://t.co/VVXXrvPuE4
Interesting, I’ve experienced the opposite problem - over calling BG by 1-1.5 mmol.l - Of course,im not exactly a paediatric patient. #fingerpricksrule
https://t.co/ibq3ZL2lTq
What an amazing editorial by Sniderman et al - sadly firewalled - "Incorporating apoB and Lp(a) into routine clinical care will improve assessment of CV risk due to the apoB lipoproteins. Adopting apoB as the primary measure of the effectiveness of therapy will radically simplify—and therefore radically improve—the capacity of all caregivers in all parts of the world to prevent CVD. https://t.co/PNatEeAINH @nationallipid@society_eas@ASPCardio@escardio@atherosociety@FamilyHeartFdn@fhpatienteurope #cholesterol
Honey, pass the betaine- I can’t get off the couch!
Systematic profiling reveals betaine as an exercise mimetic for geroprotection: Cell https://t.co/cfVXttWehx